Various factors augur well for our expectation of a 21% sales CAGR to Rs 8 bn over FY20–23. Divi’s Labs (DIVI), in addition to having a robust base business, is …
Tag:
Divis
-
-
Divis has a consistent track record of revenue growth and margin improvement. Divi’s Laboratories (Divis) reported Q3FY21 performance broadly in line with our estimates, though reported margin and PAT was …
- Business
Divi’s Laboratories: Brokerages raise target price on strong Oct-Dec quarter results, should you buy or hold?
The company informed that it has been able to normalise operations during the third quarter of the current fiscal. Divi’s Laboratories Ltd share price fell as much as 3 per …
-
A few hundred protesters, led by women, on Thursday allegedly damaged property, machinery and the protection wall on the 498-acre site proposed for a pharma company by Divi’s Laboratories Limited …
